INTRODUCTION
Diadenosine 5',5"'-P',P3-triphosphate (Ap3A) and diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) are the most abundant of the diadenosine polyphosphates, a family of naturally occurring molecules consisting of two adenosine groups linked by a variable number of phosphate groups. Diadenosine polyphosphates have been detected in a wide variety of cells [1] and are stored at high concentration in platelets and chromaffin cells. Ap3A, Ap4A, Ap5A and Ap6A are stored in the dense bodies of platelets and, upon platelet aggregation, are released into the extracellular milieu [2] [3] [4] . In chromaffin cells, Ap4A, Ap5A [5] and Ap6A [6] are co-stored with AMP, ADP, ATP and catecholamines. It has been estimated that, following release from platelets and chromaffin cells, diadenosine polyphosphates could be present at micromolar concentrations in the extracellular fluid [7, 8] . Since diadenosine polyphosphates could reach physiologically significant concentrations and, compared with ATP, have relatively long half-lives in blood [9] , it is apparent that they are well-suited to their emerging role as extracellular effectors. Indeed, diadenosine polyphosphates have been shown to modulate a number of biological processes including platelet aggregation [10] [11] [12] , catecholamine release from chromaffin cells [13] and vasoregulation [4, 7, 14] .
The biological effects of diadenosine polyphosphates on a number of cells and tissues have been attributed to interactions with known P2-purinoceptors (as defined by the classification of Burnstock and Kennedy [15] ) for ADP and ATP. Thus, ATP and Ap3A-induced transients, like ADP-induced transients, through an increase in both the peak [Ca2+] , and the frequency of the transients. In contrast, Ap4A-induced transients, like ATPinduced transients, develop an increased duration or a sustained rise in [Ca2l] ,, with no rise in peak [Ca2+]1. (3) Ap3A-induced transients, like ADP-induced transients, are abolished by low concentrations of the phorbol ester 4,6-phorbol 12,13-dibutyrate (PDB; 5-10 nM), whereas long Ap4A-induced transients, like long ATP-induced transients, are refractory to high concentrations of PDB (100 nM). We propose that the [Ca2+], oscillations induced in rat hepatocytes by Ap3A are mediated by the same purinoceptor that mediates the effects of ADP, whereas the oscillations induced by Ap4A are mediated by the same purinoceptor(s) that mediate the effects of ATP.
Ap4A have been reported to activate the same receptor to induce cation currents in rat sensory neurons [16] . Ap6A acts on P2X-purinoceptors to stimulate contraction of the urinary detrussor muscle in human bladder [17] . In chromaffin cells Ap4A and Ap5A act via a putative P2y-purinoceptor [8] to evoke an increase in cytosolic free Ca2+ concentration ([Ca2+]1) [18] and an activation of protein kinase C [19] . In contrast, however, it has been proposed that, in some cells and tissues, diadenosine polyphosphates may act via unique receptors highly specific for diadenosine polyphosphates. For example, it has been suggested that Ap4A and Ap5A may act via a separate sub-type of receptors, distinct from that for ATP, to induce contraction of rat vas deferens [20] . In intact rabbit hearts, Ap3A and Ap4A exert specific effects that are not seen in response to adenosine, AMP, ADP or ATP; it was thus suggested that specific receptors for the diadenosine polyphosphates may exist on endothelial and/or smooth-muscle cells of the vascular wall of coronary arteries [7] . On the basis of displacement binding studies, which revealed the presence of binding sites for Ap4A whose agonist affinity series differed from any previously described P2-purinoceptor, the existence on rat brain synaptosomes of a unique purinoceptor with high affinity for diadenosine polyphosphates has been suggested [21] . Indeed, a unique membrane receptor for ApNA has been identified in mouse brain. This dipurinoceptor was also detected in several other mouse tissues, including heart, muscle and liver [22] .
In perfused isolated rat liver, Ap3A and Ap4A stimulate glucose output and a transient net release of Ca2+ [23] . In isolated Abbreviations used: Ap3A, diadenosine 5',5"'-P',P3-triphosphate; Ap4A, diadenosine 5',5"'-P1,P4-tetraphosphate; Ap5A, diadenosine 5 hepatocytes, a series of diadenosine polyphosphates stimulate a dose-dependent activation of glycogen phosphorylase similar to that observed with ATP [24] . Extracellular ADP and ATP act on rat hepatocytes to stimulate the hydrolysis of Ptdlns(4,5)P2 and subsequent mobilization of Ca2+ [25] . We 
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Single hepatocytes were isolated from fed 150-250 g male Wistar rats by collagenase digestion as described previously [32] . Collagenase was from Boehringer. Microdialysis and microinjection of aequorin, data acquisition and analysis were described previously [36] . Ap4A-induced oscillations were also potentiated by the coapplication of L858051; however, the modulatory effects of elevated intracellular cyclic AMP concentration on individual [Ca2+]1 transients differed markedly from the effect on Ap3A-induced transients. As shown in Figure 4(a) , the co-application of L858051 (5,M) to hepatocytes responding to Ap4A alone by the generation of short transients stimulated an increase in the duration of the transients (7/7 cells). In hepatocytes responding to Ap4A alone with transients oflong duration, the co-application of L858051 (5 ,M) stimulated either an increase in the duration of each transient (7/8 cells; Figure 4b Figure 4 (d). As described previously [34] , the co-application of L858051 exerted similar modulatory effects on ATP-induced transients. Figures 4a, 4b and 4d) . A similar effect on ATP-induced transients was previously reported [34] .
These data thus demonstrate a further difference between the oscillatory [Ca2+], responses to Ap3A and Ap4A. Instead, the sients. Figure 5 shows a typical result in which Ap3A-induced [Ca2+]i oscillations were promptly abolished by the co-application of 5 nM PDB. As a control, the inactive phorbol ester 4a-PDB (10 nM) had no effect on Ap3A-induced [Ca2+]i oscillations (3/3 hepatocytes).
As described previously, ATP-induced [Ca2+]1 oscillations of long duration were resistant to PDB, even, in the majority of hepatocytes, at greatly elevated concentrations (100 nM) [35] . We therefore decided to examine the impact of PDB on long The intracellular cyclic AMP concentration was elevated by the co-application of 5 ,uM L858051 for the periods indicated. [24] . Furthermore, in the present studies, the single hepatocyte is held in isolation from all other cells and is constantly superfused with medium, which thereby simultaneously provides a continuous supply of fresh Ap3A or Ap4A and removes any breakdown products. The accumulation of ADP and ATP at the cell surface is thus prevented. In addition, we have previously demonstrated that diadenosine 5',5"'-P_,P3-(P1-thio)triphosphate (mixed isomers) and (SpSp)diadenosine 5',5"'-Pl,P'-dithiotetraphosphate, phosphorothioate analogues of Ap3A and Ap4A respectively, induce
[Ca2+]i oscillations in single rat hepatocytes [26] . Compared with Ap3A and Ap4A, these analogues show a much slower rate of cleavage by specific Ap3A and Ap4A hydrolases and non-specific phosphodiesterases [41] . It is thus apparent that the intact diadenosine polyphosphates are able to induce [Ca2+]i oscillations in single rat hepatocytes. The ability to respond to Ap3A and Ap4A may represent an important physiological role for the ADP and ATP receptors on rat hepatocytes. If the distribution of these receptors is not restricted to rat hepatocytes, it must be considered that any cell type expressing these receptors is a potential target for the actions of Ap3A and Ap4A. Ap3A and Ap4A are longer-lasting signalling molecules than ADP and ATP and may be able to act upon target tissues relatively distant from their site of liberation [9] . Furthermore, compared with ADP and ATP, Ap3A and Ap4A are degraded more slowly by ecto-nucleotidases on the surface of various potential target cells [42] . It is therefore tempting to speculate that, in vivo, Ap3A and Ap4A may have a more important role than ADP and ATP as extracellular effectors, particularly at targets remote from the release site. Indeed, Ap3A and Ap4A may represent the true physiological agonists of the previously postulated ADP, ATPS and ATPL receptors [27, 34, 35] .
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